Health Care & Life Sciences M&A Webinar Series

The global COVID-19 pandemic completely disrupted health care and life sciences transactional activity in the United States. However, it is clear investors, lenders, and strategics are learning how to get back to business despite the challenges. Middle-market deal activity is on the rise, and we have seen many large cap transactions close in recent months.

This informative webinar series is designed to help stakeholders as they begin to get back into acquisition and growth mode, as well as provide new entrants into the marketplace with an understanding of major issues. Sessions in the series will explore regulatory, enforcement, and litigation issues impacting health care and life sciences M&A. Speakers will identify issues that influence health care and life sciences deal activity, explore their impact, and discuss how stakeholders can best position themselves for success.

 

Webinars

Key Regulatory Diligence Considerations – October 21, 2020
This webinar discussed the major areas of regulatory risk in acquiring a health care services business and the importance of the breadth and depth of different types of areas of inquiry. Listen to the webinar here.

Life Sciences and FDA Diligence – November 18, 2020
Reed Stephens discussed the major areas of regulatory risk in acquiring businesses in the life sciences industry and/or regulated by food and drug law. Listen to the webinar here.

Fraud and Abuse Issues in Health Care Services Transactions – December 16, 2020 
Amandeep Sidhu and Guy Collier explored the most prevalent fraud and abuse issues in health care services transactions—as well as some important topics that may fly under the radar. Listen to the webinar here.

Health Care Fraud and Abuse Issues in Life Sciences Transactions – February 17, 2021
Reed Stephens and Amandeep Sidhu discussed fraud and abuse issues that keep leaders in the life sciences industry up at night. Topics included federal and state Anti-kickback laws, the False Claims Act, and the importance of having a robust risk-based compliance program. Listen to the webinar here.

Licensure and Provider Number Change of Ownership and Structuring Issues in Health Services Transactions – March 17, 2021
This webinar discussed the basics of CHOW issues for licensure and provider numbers. Our team covered topics such as licensing and disclosures and the structuring necessary for certain types of transactions. 

Regulatory Reps/Warranties in Transaction Documents – May 12, 2021
With the multitude of health care reps and warranties types, it can be hard to know what they cover. And more importantly, how do you allocate risk? In the sixth episode of our series, we covered the ins and outs of regulatory reps and warranties in transaction documents and beyond. Listen to the webinar here.